English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/212398
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Association between fatty acids of blood cell membranes and incidence of coronary heart disease

Other TitlesA case-control study nested in the PREDIMED trial
AuthorsPapandreou, Christopher; Sala-Vila, Aleix; Galié, Serena; Muralidharan, Jananee; Estruch, Ramón; Fito, Montserrat; Razquin, Cristina; Corella, Dolores; Ros, Emilio; Timiraos, Juan; Lapetra, Jose; Serra-Majem, Lluis; Carlos, Silvia; Castaner, Olga; Asensio, Eva M.; Salas-Salvadó, Jordi; Bulló, Mònica
Issue Date2019
PublisherLippincott Williams & Wilkins
CitationArteriosclerosis, Thrombosis, and Vascular Biology 39(4): 819-825 (2019)
Abstract[Objective]: To examine the associations between baseline levels of fatty acids in blood cell membranes and their 1-year changes with the incidence of coronary heart disease (CHD) in older adults at high cardiovascular disease risk. [Approach and Results]: This is a case-control study nested in the PREDIMED trial (Prevención con Dieta Mediterránea), with 136 CHD cases and 272 controls (matched on age, sex, body mass index, intervention group, and time of permanence in the study to the time event). We used gas chromatography to measure the proportion of 22 fatty acids in blood cell membranes at baseline and after 1 year. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% CIs. After adjustment for classical CHD risk factors and multiple testing, 1 SD increase in baseline levels of C22:0, C24:0 and the sum of individual very long chain saturated fatty acids was associated with 56% (OR, 0.44 [95% CI, 0.28–0.69]), 59% (OR, 0.41 [95% CI, 0.25–0.65]), and 55% (OR, 0.45 [95% CI, 0.29–0.70]) a decreased odds of developing CHD, respectively. Baseline C20:1n9 was associated with higher odds of CHD (OR, 1.58 [95% CI, 1.25–2.00]). [Conclusions]: Higher levels of C22:0 and C24:0 were associated with a lower CHD incidence, whereas higher levels of C20:1n9 were associated with a higher risk. This study adds to the growing body of evidence suggesting potential differences in the cardiovascular disease effects of different types of circulating saturated fatty acids.
Publisher version (URL)https://doi.org/10.1161/ATVBAHA.118.312073
URIhttp://hdl.handle.net/10261/212398
Identifiersdoi: 10.1161/ATVBAHA.118.312073
issn: 1079-5642
e-issn: 1524-4636
Appears in Collections:(IBIS) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.